Marko Manevski
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Neonatal Respiratory Health Research 2
-
- RNA modifications and cancer 2
- Co-authors
- Dinesh Devadoss (11 shared papers)Irfan Rahman (5 shared papers)Hitendra S. Chand (11 shared papers)Glen M. Borchert (5 shared papers)Raymond J. Langley (2 shared papers)Nazira El‐Hage (3 shared papers)Christopher J. Long (2 shared papers)Kameshwar P. Singh (1 shared paper)
- Journals
- Toxicology Reports (3 papers)Frontiers in Immunology (2 papers)iScience (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesPoland
In The Last Decade
Marko Manevski
15 papers receiving 286 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 66
- Infectious Diseases 61
- Physiology 62
- Aging 4
- Modeling and Simulation 10
Countries citing papers authored by Marko Manevski
This map shows the geographic impact of Marko Manevski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Manevski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Manevski more than expected).
Fields of papers citing papers by Marko Manevski
This network shows the impact of papers produced by Marko Manevski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Manevski. The network helps show where Marko Manevski may publish in the future.
Co-authors
The 25 scholars most cited alongside Marko Manevski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 51 | |
| 2 | 2023 | 47 | |
| 3 | 2019 | 45 | |
| 4 | 2022 | 39 | |
| 5 | 2021 | 16 | |
| 6 | 2022 | 16 | |
| 7 | 2020 | 15 | |
| 8 | 2020 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2020 | 3 | |
| 15 | 2021 | 1 |
About Marko Manevski
Marko Manevski is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Health, Toxicology and Mutagenesis and Epidemiology, having authored 15 papers that have together received 288 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Air Quality and Health Impacts (3 papers), Smoking Behavior and Cessation (2 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers), Neonatal Respiratory Health Research (2 papers) and HIV Research and Treatment (1 paper). The work is most often cited by research in Cancer Research (66 citations), Infectious Diseases (61 citations), Physiology (62 citations), Aging (4 citations) and Modeling and Simulation (10 citations). Marko Manevski has collaborated with scholars based in United States and Poland. Frequent co-authors include Dinesh Devadoss, Irfan Rahman, Hitendra S. Chand, Glen M. Borchert, Raymond J. Langley, Nazira El‐Hage, Christopher J. Long, Kameshwar P. Singh, Qixin Wang and Madhavan Nair. Their work appears in journals such as Toxicology Reports, Frontiers in Immunology, iScience, Frontiers in Cellular and Infection Microbiology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.